To mark the second anniversary of the Oct. 7 attacks in Israel, the Jewish Insider team asked leading thinkers and ...

Sanofi recently announced that its investigational radiopharmaceutical therapy, AlphaMedix™, met all primary efficacy endpoints in a Phase II trial for patients with unresectable or metastatic ...

Scott Nuzum of Wiley discusses legal, structural, and commercial strategy required for international dual-use technology ...

Zimmer Biomet is undervalued despite recent underperformance, backed by innovation, acquisitions, and strong cash flow. Learn ...

Vacant and struggling shopping malls are increasingly being seen by U.S. developers as opportunities to build more housing units.

Discover how Abacus Global Management taps into a $100B life insurance lapse market with strong growth and high margins. Read ...

New, high-quality research quantifying the powerful impact of federal non-defense research and development shows why the dramatic cuts to non-defense R&D funding proposed by the Trump Administration ...

Vara Kumar is the co-founder and Head of R&D and Solutions at Whatfix, driving innovation and strategic growth for the ...

US President Donald Trump’s second State visit to the UK featured lavish royal ceremonies, record US investments worth £150 billion, and the signing of a landmark Tech Prosperity Deal with PM Keir ...

China is in the driver’s seat when it comes to EV technology—which poses huge defense implications for the U.S.